NCT05996614

Brief Summary

  1. 1.To evaluate the effect of the platelet rich plasma on the take of split thickness skin graft and its early and late results in resurfacing of post burn raw areas.
  2. 2.To evaluate the effect of PRP on wound healing on skin graft donor site.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2022

Completed
11 months until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

August 18, 2023

Status Verified

August 1, 2023

Enrollment Period

1.2 years

First QC Date

October 7, 2022

Last Update Submit

August 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • histopathological biopsy from both groups by punch Biopsy (vancouver scale )

    pigmentation (0-2) ,normal 0, Hypopigmentation 1 ,Hyperpigmentation 2 Vascularity (0-3) ,Normal 0, Pink 1, Red 2, Purple 3 Pliability (0-5) Normal 0 ,Supple 1 ,Yielding 2,Firm 3, Banding 4, Contracture 5 Height (0-3) Normal(flat)0 ,(0-2mm)1,(2-5mm)2,(\>5mm)3

    3 months

Study Arms (2)

group with PRP

EXPERIMENTAL

Group of patients with post burn raw areas treated with application of platelet rich plasma

Procedure: PRP in skin grafts

group without PRP

EXPERIMENTAL

Group of patients with post burn raw areas treated with conventional methods

Procedure: conventional methods in skin grafts

Interventions

topical application of platelet rich plasma before resurfacing with STSG in Post burn raw areas

group with PRP

fixation of the graft with stitches and staplers

group without PRP

Eligibility Criteria

Age15 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age (15- 60 years).
  • Post burn Raw area less than 10 % of total body surface area .
  • Selected donor sites.

You may not qualify if:

  • Raw area due to other causes ( trauma, ischemia,..etc)
  • Patients with bleeding tendency.
  • Patients with comorbidities(diabetes, malignancy,..etc)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Garcia-Sanchez JM, Mirabet Lis V, Ruiz-Valls A, Perez-Plaza A, Sepulveda Sanchis P, Perez-Del-Caz MD. Platelet rich plasma and plasma rich in growth factors for split-thickness skin graft donor site treatment in the burn patient setting: A randomized clinical trial. Burns. 2022 Nov;48(7):1662-1670. doi: 10.1016/j.burns.2021.10.001. Epub 2021 Oct 22.

MeSH Terms

Conditions

Paresthesia

Interventions

Skin Transplantation

Condition Hierarchy (Ancestors)

Somatosensory DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Tissue TransplantationCell- and Tissue-Based TherapyBiological TherapyTherapeuticsDermatologic Surgical ProceduresPlastic Surgery ProceduresSurgical Procedures, OperativeTransplantation

Study Officials

  • Mostafa Elsonbaty, prof

    Assiut University

    STUDY CHAIR

Central Study Contacts

Ibrahim Ragab Ibrahim, master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

October 7, 2022

First Posted

August 18, 2023

Study Start

October 1, 2023

Primary Completion

December 1, 2024

Study Completion

February 1, 2025

Last Updated

August 18, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share